Methotrexate resistance in NIH3T3 cells expressing polyoma virus oncogenes

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• NIH3T3 cell lines are widely used models for studying cellular transformation and oncogene function.
• Methotrexate (MTX) resistance is a common phenomenon in cancer cells, often mediated by alterations in the dihydrofolate reductase (dhfr) gene.
• Polyoma virus oncogenes are known to induce cellular immortalization and transformation.

Purpose of the Study:

• To investigate the effect of different polyoma virus oncogenes on the frequency of methotrexate resistance in NIH3T3 cells.
• To determine if dhfr gene amplification is the primary mechanism of MTX resistance in these cell lines.
• To explore potential epigenetic mechanisms underlying MTX resistance induced by polyoma oncogenes.

Main Methods:

• Single-step selection of methotrexate-resistant (MTXr) colonies in NIH3T3 cell lines expressing different polyoma virus oncogenes (small T, middle T, large T) or a cloning vector.
• Analysis of dhfr gene amplification in MTXr colonies using quantitative methods.
• Comparison of MTXr frequencies and dhfr gene amplification levels across different cell lines.

Main Results:

• Frequencies of MTXr cells varied by nearly three orders of magnitude depending on the expressed polyoma oncogene.
• Cells expressing small T antigen showed the highest MTXr frequencies, while middle T antigen expressing cells showed the lowest.
• dhfr gene amplification was not the primary mechanism for MTX resistance; instead, epigenetic mechanisms may be involved, particularly with small T and large T antigens.

Conclusions:

• Polyoma virus oncogenes do not increase genome plasticity related to dhfr gene amplification.
• Oncogenes can influence MTX resistance through epigenetic modifications, independent of dhfr gene amplification.
• Mechanisms of resistance other than dhfr gene amplification are crucial for understanding varied MTX resistance frequencies.